Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
RCUS
RCUS News & Events
-
Add to Watchlist
Trade RCUS
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
RCUS News
Arcus Biosciences Grants Employee Stock Options
Apr 24 2026
Newsfilter
Arcus Biosciences Halts Late-Stage Lung Cancer Trial
Apr 20 2026
seekingalpha
ARCUS BIOSCIENCES INC - SEC FILING ANNOUNCES DISCONTINUATION OF STAR-121 AND PHASE 2 EDGE-LUNG STUDIES
Apr 20 2026
moomoo
Arcus Biosciences Grants Employee Stock Options
Apr 09 2026
Newsfilter
Arcus Biosciences Grants Stock Options to New Employees
Mar 24 2026
Newsfilter
Arcus Biosciences Grants Stock Options to New Employees
Mar 09 2026
Newsfilter
Arcus (RCUS) Q4 2025 Earnings Call Transcript
Feb 26 2026
NASDAQ.COM
Arcus Biosciences Q4 Earnings Beat Expectations
Feb 25 2026
seekingalpha
Show More News
RCUS Events
04/22 10:10
Arcus Biosciences Stock Rises 12.2% to $27.50
Arcus Biosciences is up 12.2%, or $2.98 to $27.50.
Show More Events
RCUS Monitor News
Arcus Biosciences halts STAR-121 trial amid poor clinical prospects
Apr 22 2026
Arcus Biosciences halts STAR-121 trial amid poor clinical prospects
Apr 21 2026
Arcus Biosciences halts STAR-121 trial due to futility
Apr 20 2026
Arcus Biosciences Reports Q4 Earnings Beat Expectations
Mar 02 2026
Analyst ratings adjustments influence market sentiment
Feb 12 2026
Arcus Biosciences Advances Casdatifan Phase 3 Trials
Jan 14 2026
Arcus Biosciences Advances Casdatifan Phase 3 Trials
Jan 13 2026
Arcus Biosciences stock drops amid market decline
Dec 12 2025
Show More Monitor News
RCUS Earnings Analysis
No Data
People Also Watch
